Exosomes: A Promising Avenue for the Diagnosis of Breast Cancer
- PMID: 30760122
- PMCID: PMC6373987
- DOI: 10.1177/1533033818821421
Exosomes: A Promising Avenue for the Diagnosis of Breast Cancer
Abstract
Currently, despite the advances in individualized treatment, breast cancer still remains the deadliest form of cancer in women. Diagnostic, prognostic, and therapy-predictive methods are mainly based on the evaluation of tumor tissue samples and are aimed to improve the overall therapeutic level. Therefore, the exploration of a series of circulating biomarkers, which serve as the information source of tumors and could be obtained by peripheral blood samples, represents a high field of interest. Apart from classical biomarkers, exosomes, which are nanovesicles, are emerging as an accessible and efficient source of cell information. The purpose of this review is to summarize the peculiarities of the presently available breast cancer exosomal biomarkers; the review also provides the prediction of a multitude of potential target genes of exosomal microRNAs using 4 databases.
Keywords: breast cancer; diagnostics; exosome; miRNA; protein.
Conflict of interest statement
Figures
Similar articles
-
Exosomal miRNA profile as complementary tool in the diagnostic and prediction of treatment response in localized breast cancer under neoadjuvant chemotherapy.Breast Cancer Res. 2019 Feb 6;21(1):21. doi: 10.1186/s13058-019-1109-0. Breast Cancer Res. 2019. PMID: 30728048 Free PMC article.
-
ExoBCD: a comprehensive database for exosomal biomarker discovery in breast cancer.Brief Bioinform. 2021 May 20;22(3):bbaa088. doi: 10.1093/bib/bbaa088. Brief Bioinform. 2021. PMID: 32591816
-
Exosomes in breast cancer management: Where do we stand? A literature review.Biol Cell. 2022 Apr;114(4):109-122. doi: 10.1111/boc.202100081. Epub 2022 Feb 3. Biol Cell. 2022. PMID: 35080041 Review.
-
Exosome-encapsulated microRNAs as circulating biomarkers for breast cancer.Int J Cancer. 2016 Oct 1;139(7):1443-8. doi: 10.1002/ijc.30179. Epub 2016 May 31. Int J Cancer. 2016. PMID: 27170104 Review.
-
Plasma exosome microRNAs are indicative of breast cancer.Breast Cancer Res. 2016 Sep 8;18(1):90. doi: 10.1186/s13058-016-0753-x. Breast Cancer Res. 2016. PMID: 27608715 Free PMC article.
Cited by
-
Circulating tumor biomarkers in early-stage breast cancer: characteristics, detection, and clinical developments.Front Oncol. 2023 Oct 24;13:1288077. doi: 10.3389/fonc.2023.1288077. eCollection 2023. Front Oncol. 2023. PMID: 37941557 Free PMC article. Review.
-
Current and Developing Liquid Biopsy Techniques for Breast Cancer.Cancers (Basel). 2022 Apr 19;14(9):2052. doi: 10.3390/cancers14092052. Cancers (Basel). 2022. PMID: 35565189 Free PMC article. Review.
-
The Role of Exosomal MicroRNAs in the Tumor Microenvironment of Breast Cancer.Int J Mol Sci. 2019 Aug 9;20(16):3884. doi: 10.3390/ijms20163884. Int J Mol Sci. 2019. PMID: 31395836 Free PMC article. Review.
-
Noncoding RNAs in Extracellular Fluids as Cancer Biomarkers: The New Frontier of Liquid Biopsies.Cancers (Basel). 2019 Aug 14;11(8):1170. doi: 10.3390/cancers11081170. Cancers (Basel). 2019. PMID: 31416190 Free PMC article. Review.
-
Advances of Exosomal miRNAs in Breast Cancer Progression and Diagnosis.Diagnostics (Basel). 2021 Nov 20;11(11):2151. doi: 10.3390/diagnostics11112151. Diagnostics (Basel). 2021. PMID: 34829498 Free PMC article. Review.
References
-
- Cooney MA, Culletonquinn E, Stokes E. Current knowledge of pain after breast cancer treatment: a systematic review. Pain Manag Nurs. 2013;14(2):110–123. - PubMed
-
- Ahmed M, Rubio IT, Klaase JM, Douek M. Surgical treatment of nonpalpable primary invasive and in situ breast cancer. Nat Rev Clin Oncol. 2015;12(2):645–663. - PubMed
-
- Takahashi TA, Lee CI, Johnson KM. Breast cancer screening: does tomosynthesis augment mammography? Cleve Clin J Med. 2017;84(7):522–527. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical